These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5523126)

  • 1. Attempts towards oral diabetes therapy by means of inhibition of lipolysis with 5-methylpyrazole-3-carbonic acid.
    Beringer A; Bänder A; Glaninger J; Mayrhofer E; Schnack H
    Horm Metab Res; 1970 Mar; 2(2):81-5. PubMed ID: 5523126
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of the lipolysis blocker 5-methylpyrazol-3-carbonic acid (MPC) on changes in carbohydrate and lipid metabolism induced by muscle work in insulin-requiring diabetics].
    Schulz B; Michaelis D; Neumann I; Schäfer H; Wulfert P
    Z Gesamte Inn Med; 1973 Jun; 28(12):345-50. PubMed ID: 4729261
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of methylpyrazole-carboxylic acid on carbohydrate and lipid metabolisms in patients with diabetes mellitus].
    Lang PD; Wahl P; Hassalacher Ch; Vollmar J
    Arzneimittelforschung; 1975 Jan; 25(1):117-20. PubMed ID: 807221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of lipolysis and its inhibition on the diabetic metabolic disorders and cholesterol levels].
    Beringer A; Bänder A; Glaninger J; Mayerhofer E
    Wien Z Inn Med; 1971; 52(1):1-14. PubMed ID: 5540814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of combined acute 5-methylpyrazol-3-carbonic acid and insulin loading on the carbohydrate and lipid metabolism parameter in patients with diabetes].
    Zander E; Michaelis D; Wulfert P; Schümann H
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2131-4. PubMed ID: 4650682
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 5-methylpyrazol-3-carbonic acid on the norepinephrine-induced lipolysis in diabetics of labile and stabile metabolic type].
    Michaelis D; Neumann I; Wulfert P; Müller F
    Wien Z Inn Med; 1971; 52(8):409-16. PubMed ID: 5110845
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of diabetes or hyperglycemia on lipid metabolism and urea formation by the perfused rat liver.
    Penhos JC; Basabe JC; Lopez N; Levine R
    Horm Metab Res; 1971 Jan; 3(1):10-20. PubMed ID: 5128323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of insulin and lipolytic blockaders on changes in fat metabolism caused by muscular activity in diabetic patients].
    Schulz B; Michaelis D; Neumann I; Wulfahrt P
    Probl Endokrinol (Mosk); 1974; 20(1):24-8. PubMed ID: 4848587
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. II. Antilipolytic and hypoglycemic effects in vivo.
    Froesch ER; Waldvogel M; Meyer UA; Jakob A; Labhart A
    Mol Pharmacol; 1967 Sep; 3(5):442-52. PubMed ID: 6052709
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of carbohydrate and lipid metabolism parameters and of 11-hydroxycorticoids in insulin-needing diabetics under long-term therapy using 5-methylpyrazole-3-carboxylic acid].
    Neumann I; Michaelis D; Bibergeil H; Wulfert P
    Dtsch Gesundheitsw; 1972 May; 27(21):972-6. PubMed ID: 4625279
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination].
    Beringer A
    Minerva Med; 1974 Sep; 65(60):3127-39. PubMed ID: 4214043
    [No Abstract]   [Full Text] [Related]  

  • 14. Exercise and diabetes mellitus: physical activity as a part of daily life and its role in the treatment of diabetic patients.
    Kemmer FW; Berger M
    Int J Sports Med; 1983 May; 4(2):77-88. PubMed ID: 6347917
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal nutrition in man: anesthesiologic implications.
    Brunner EA
    Anesth Analg; 1971; 50(4):620-4. PubMed ID: 5105115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of 3,5-dimethylisoxazol short-term administration on the carbohydrate metabolism in elderly diabetics with secondary failure of sulfonylurea treatment].
    Geyer G; Sokopp B
    Wien Klin Wochenschr; 1969 Oct; 81(40):701-5. PubMed ID: 5344305
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.
    Raz I; Eldor R; Cernea S; Shafrir E
    Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose tissue lipolysis in golden hamsters with chronic hypoglycemia and hyperinsulinemia due to a transplantable islet cell tumor.
    Lefebvre PJ; Sodoyez JC; Luyckx AS; Foà PP
    Horm Metab Res; 1970 Mar; 2(2):64-7. PubMed ID: 4329446
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
    Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
    Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of fatty acid ingestion upon oral glucose tolerance.
    Szabo O; Mahler RJ
    Horm Metab Res; 1971 Jul; 3(4):299-300. PubMed ID: 5129994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.